Parkman Healthcare Partners LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 1777015 STAMFORD, CT

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,805,225

+$5,951,376 QoQ

Shares Held

253,365

+153.0% QoQ

Ownership

0.146%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#89

of 321 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. COGT ranks #23 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MBX	MBX Biosciences, Inc.	800,173	$44,169,549
2	PTCT	Ptc Therapeutics, Inc.	435,691	$35,539,314
3	RCUS	Arcus Biosciences, Inc.	919,266	$28,340,970
4	GPCR	Structure Therapeutics Inc.	485,661	$26,065,425
5	VRDN	Viridian Therapeutics, Inc.\DE	1,377,576	$25,306,071
6	AGIO	Agios Pharmaceuticals, Inc.	669,046	$24,828,297
7	INBX	Inhibrx Biosciences, Inc.	256,950	$24,346,012
8	XENE	Xenon Pharmaceuticals Inc.	397,379	$23,985,796

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,805,225	253,365	+153.0%	Shares	Sole	2026-08-14
2026-03-31	$3,853,849	100,126	+3.4%	Shares	Sole	2026-05-15
2023-12-31	$569,401	96,837	-50.0%	Shares	Sole	2024-02-14
2023-09-30	$1,887,960	193,637	+4.2%	Shares	Sole	2023-11-14
2023-06-30	$2,199,658	185,782	+2.1%	Shares	Sole	2023-08-11
2023-03-31	$1,962,657	181,896	+28.5%	Shares	Sole	2023-05-12
2022-12-31	$1,636,687	141,582	-40.2%	Shares	Sole	2023-02-13
2022-09-30	$3,531,519	236,697	-18.0%	Shares	Sole	2022-11-14
2022-06-30	$2,604,525	288,750	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.